Additional Four million doses of Moderna COVID-19 Vaccine purchased by Canada

Published On 2021-02-14 04:00 GMT   |   Update On 2021-02-16 03:13 GMT

Cambridge:Moderna has recently announced that the Canadian Government has increased its confirmed order commitment by 4 million doses of the COVID-19 Vaccine Moderna bringing its confirmed order commitment to 44 million doses. This increase reflects continued efforts by the Canadian Government to secure access to safe and effective COVID-19 vaccines for Canadian citizens."We appreciate...

Login or Register to read the full article

Cambridge:Moderna has recently announced that the Canadian Government has increased its confirmed order commitment by 4 million doses of the COVID-19 Vaccine Moderna bringing its confirmed order commitment to 44 million doses. This increase reflects continued efforts by the Canadian Government to secure access to safe and effective COVID-19 vaccines for Canadian citizens.

"We appreciate our collaboration with the Canadian government as we seek to defeat the pandemic with our vaccine. Increased supply agreement from the Canadian government reaffirms the confidence in Moderna's COVID-19 vaccine," said Stephane Bancel, Chief Executive Officer of Moderna.

On December 23, Health Canada authorized the COVID-19 Vaccine Moderna for the immunization of people 18 years of age and older under an Interim Order.

Moderna COVID-19 Vaccine (mRNA-1273 SARS-CoV-2 vaccine) is indicated for active immunization against coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus in individuals 18 years of age and older.

Moderna is advancing messenger RNA (mRNA) science to create a new class of transformative medicines for patients.
mRNA medicines are designed to direct the body's cells to produce intracellular, membrane or secreted proteins that can have a therapeutic or preventive benefit and have the potential to address a broad spectrum of diseases. 
Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News